Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Benjamin Edwards Inc.

Benjamin Edwards Inc. increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 148.7% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 13,673 shares of the medical equipment provider’s stock after acquiring an additional 8,176 shares during the period. Benjamin Edwards Inc.’s holdings in Intuitive Surgical were worth $6,718,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Valeo Financial Advisors LLC raised its position in shares of Intuitive Surgical by 9.8% in the 2nd quarter. Valeo Financial Advisors LLC now owns 3,639 shares of the medical equipment provider’s stock valued at $1,619,000 after purchasing an additional 326 shares in the last quarter. Warther Private Wealth LLC bought a new position in Intuitive Surgical during the 2nd quarter valued at $484,000. Salem Investment Counselors Inc. grew its holdings in Intuitive Surgical by 2.0% during the 2nd quarter. Salem Investment Counselors Inc. now owns 62,231 shares of the medical equipment provider’s stock worth $27,683,000 after acquiring an additional 1,206 shares in the last quarter. Strategic Advocates LLC increased its position in shares of Intuitive Surgical by 1.9% in the 2nd quarter. Strategic Advocates LLC now owns 10,013 shares of the medical equipment provider’s stock worth $4,454,000 after purchasing an additional 184 shares during the last quarter. Finally, Cherrydale Wealth Management LLC acquired a new stake in shares of Intuitive Surgical in the 2nd quarter valued at about $207,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on ISRG shares. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a report on Friday, October 18th. Stifel Nicolaus raised their price objective on Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Citigroup boosted their target price on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Robert W. Baird raised their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Finally, Leerink Partners boosted their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $536.61.

Intuitive Surgical Stock Down 0.2 %

ISRG stock opened at $541.71 on Wednesday. Intuitive Surgical, Inc. has a fifty-two week low of $304.50 and a fifty-two week high of $552.00. The company has a market capitalization of $192.95 billion, a P/E ratio of 87.09, a PEG ratio of 5.34 and a beta of 1.38. The company has a 50-day simple moving average of $512.25 and a 200 day simple moving average of $471.53.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Equities analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Amy L. Ladd sold 450 shares of the stock in a transaction on Friday, September 13th. The stock was sold at an average price of $490.28, for a total transaction of $220,626.00. Following the completion of the sale, the director now owns 821 shares in the company, valued at approximately $402,519.88. This represents a 35.41 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 2,128 shares of Intuitive Surgical stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,095,920.00. Following the completion of the transaction, the senior vice president now owns 273 shares in the company, valued at $140,595. The trade was a 88.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 51,023 shares of company stock valued at $26,384,247. 0.80% of the stock is owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.